Should You Buy DexCom Stock Before Feb. 13?
DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...
Healio1d
CGM may lead to lower health care costs for pregnant women with type 1 diabetes
The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...
Does wearing a continuous glucose monitor help people without diabetes? We asked experts.
For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...
Hosted on MSN1d
Glucotrack hits trial success for direct blood measuring CGM
The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
Second, DexCom has expanded its product offerings. Last year, it launched Stelo in the U.S., an over-the-counter CGM option that can be used by pre-diabetes patients. This initiative significantly ...
What did your breakfast just do to your blood sugar? Continuous glucose monitoring can ‘empower’ the diabetic and non-diabetic alike, experts say
Monitoring of the body’s blood sugar is essential to the treatment of diabetes. But getting effective glucose readings has ...
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...
Schools aren’t as plugged in as they should be to kids’ diabetes tech, parents say
Families want nurse or staff to monitor apps remotely in case of urgent alarms; schools cite shrinking budgets and internet ...
Trinity Biotech reports findings from latest pre-pivotal trial on CGM system
Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance ...
Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years
The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the performance of many top stocks reflects this reality. DexCom (NASDAQ: DXCM) is one ...
On-Body Drug Delivery Devices Market Hits US$ 390.7 Million in 2023, Set to Reach US$ 796.1 Million by 2034 with a 6.8% CAGR | TMR Research
The On-Body Drug Delivery Devices market is witnessing significant growth, driven by the increasing demand for ...